Advertisement
Screener

ZYMEWORKS INC. (ZYME) ROE

ZYMEWORKS INC. (ZYME) ROE

  • 2026-06-30: ROE -186.63%.
  • 2026-03-31: ROE -62.75%.
  • 2025-12-31: ROE -30.22%.
  • 2025-09-30: ROE -19.82%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-186.63%
2026-03-31-62.75%
2025-12-31-30.22%
2025-09-30-19.82%
2025-06-30-22.03%
2025-03-31-34.98%
2024-12-31-36.22%
2024-09-30-30.97%
2024-06-30-27.70%
2024-03-31-28.76%
2023-12-31-25.53%
2023-09-3048.37%
2023-06-3041.45%
2023-03-3136.45%
2022-12-3125.22%
2022-09-30-124.75%
2022-06-30-106.61%
2022-03-31-84.93%
2021-12-31-85.05%

Annual ROE

DateROE
2025-12-31-30.22%
2024-12-31-36.22%
2023-12-31-25.53%
2022-12-3125.22%
2021-12-31-85.05%
2020-12-31-44.05%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Biohaven Ltd. (BHVN)United States$1.990B-3.83
COMPASS Pathways plc (CMPS)$1.812B-4.87
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Septerna, Inc. (SEPN)United States$1.783B-63.01
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Xencor Inc (XNCR)United States$1.776B-7.33